Related Experiment Video
Updated: Aug 5, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15
Qinglian Hua1, Qiyu Ma1, Huaxi Yi1
1College of Food Science and Engineering, Ocean University of China, Qingdao 266000, China.
Abstract:
Sarcopenia is a major global health challenge associated with aging, and effective pharmacological treatments are lacking. This study investigated how bile salt hydrolase (BSH)-active probiotics alleviate sarcopenia through bile acid deconjugation and remodeling, activating the intestinal FXR-FGF15/19 signaling pathway, and explored their application in functional dairy products. Three high-BSH strains-Lactiplantibacillus plantarum H-87, Bifidobacterium animalis F1-7, and F1-3-2-were identified, among which F1-7 and F1-3-2 showed superior efficacy in a dexamethasone-induced sarcopenia model. These strains improved muscle mass, morphology (including increased muscle fiber cross-sectional area and improved histological integrity), and performance by modulating gut microbiota, optimizing bile acid composition, and enhancing ileal FXR-FGF15 signaling to activate the muscle FGFR4/KLB pathway and inhibit protein degradation. Furthermore, fermented milk produced with F1-7 and F1-3-2 met quality standards and exhibited improved sensory properties. This study provides a mechanistic basis for developing probiotic dairy products and sustainable nutritional strategies for sarcopenia.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Functions of the Gut Microbiota
Microbes in Food Production
Microbiota Modulation by Antibiotics
Development of Human Microbiota
Microbes in the Production of Fermented Foods